After the initial 36 weeks, participants lost 21.1% of their body weight After the following 52 weeks, the tirzepatide group lost another 6.7% of their body weight, while the placebo group regained 14.8% Through the 88-week study, the tirzepatide group lost 26% of their body weight Tirzepatide had a similar safety profile in SURMOUNT-3 and SURMOUNT-4 as its previous trials, most commonly citing mild-moderate gastrointestinal issues
Administer the missed dose as soon as you remember, then resume the regular schedule from that point forward
Hormonal Imbalances Persist If hormonal imbalances (cortisol, thyroid, sex hormones, leptin) contributed to your weight gain, they are still present after you stop GLP-1
This natural process of boosting your innate hormone levels offers a wide range of benefits, including: Reversing Loss of Muscle Mass Growth hormone plays a critical role in building lean muscle
Thyroid C-cell effects remain under investigation for this class
Intestinal inflammation modulates the epithelial response to butyrate in patients with inflammatory bowel disease